Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Alzheimer's Disease

Free Subscription 01.09.2025 4 Alzheimers Dement 1 Ann Neurol 1 BMC Geriatr 1 BMC Neurol 1 BMC Neurosci 1 Curr Alzheimer Res 3 J Alzheimers Dis 1 J Am Geriatr Soc 3 J Neurochem 1 J Neurol 1 J Neuropsychol 1 Neurobiol Dis 1 Neurochem Res 1 Neurol Genet 1 Neurology 2 PLoS One 1 Proc Natl Acad Sci U S A

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Alzheimers Dement

1. NILSSON J, Mecca AP, Ashton NJ, Salardini E, et al
   Associations between fluid biomarkers and PET imaging ([11C]UCB-J) of synaptic pathology in Alzheimer's disease.
   Alzheimers Dement. 2025;21:e70403.
   PubMed         Abstract available
   
   
2. FERNANDES GOMES B, Farris CM, Ma Y, Concha-Marambio L, et al
   Alzheimer's disease traits in Parkinson's disease without alpha-synuclein seeding.
   Alzheimers Dement. 2025;21:e70284.
   PubMed         Abstract available
   
   
3. DAGHLAS I, Caunca MR, Shade LMP, Nassan M, et al
   Genetically proxied blood pressure, vascular brain injury, and Alzheimer's disease pathology.
   Alzheimers Dement. 2025;21:e70515.
   PubMed         Abstract available
   
   
4. HESTON MB, Teague JP, Cody KA, Deming Y, et al
   Factors associated with age at tau pathology onset and time from tau onset to dementia in Alzheimer's disease.
   Alzheimers Dement. 2025;21:e70551.
   PubMed         Abstract available
   
   

   
   Ann Neurol

5. BUCKLEY RF, Scott M, McGrath ER, Coughlan G, et al
   Midlife Steroid-Binding Globulin Levels and In Vivo Neuroimaging Measures of Tau in Older Men and Women.
   Ann Neurol. 2025;98:524-532.
   PubMed         Abstract available
   
   

   
   BMC Geriatr

6. WANG X, Wang J, Xie Q, Wang Y, et al
   Association between estimated glomerular filtration rate and memory function mediated by brain Gray matter volumes: a cross-sectional study using the ADNI database.
   BMC Geriatr. 2025;25:628.
   PubMed         Abstract available
   
   

   
   BMC Neurol

7. XU Y, Gao Y
   The global patent landscape of the drugs for treating Alzheimer's disease from 2014-2023.
   BMC Neurol. 2025;25:361.
   PubMed         Abstract available
   
   

   
   BMC Neurosci

8. PARK BN, Kim SM, An YS
   Comparative study of (18)F-labeled PET radiopharmaceuticals in an Alzheimer's disease mouse model.
   BMC Neurosci. 2025;26:55.
   PubMed         Abstract available
   
   

   
   Curr Alzheimer Res

9. BEHROUZINIA S, Khanteymoori A
   Topological Biomarkers of Alzheimer's Disease from Functional Brain Network Analysis.
   Curr Alzheimer Res. 2025 Aug 26. doi: 10.2174/0115672050399190250815070642.
   PubMed         Abstract available
   
   

   
   J Alzheimers Dis

10. CHEN J, Lin B, Seow E, Kim S, et al
    Prediction of infusion capacity to deliver Alzheimer's disease treatments in the United States relative to expected demand.
    J Alzheimers Dis. 2025 Aug 29:13872877251372129. doi: 10.1177/13872877251372129.
    PubMed         Abstract available
    
    
11. LIN H, Huang Z, Lu J, Wang J, et al
    The asymmetry of tau deposition and its correlation with cerebral metabolic asymmetry in Alzheimer's disease.
    J Alzheimers Dis. 2025 Aug 29:13872877251372523. doi: 10.1177/13872877251372523.
    PubMed         Abstract available
    
    
12. CHEN Y, Dong C, Chen J, Li Q, et al
    Clinical observations on treating Alzheimer's disease with umbilical cord blood mononuclear cells.
    J Alzheimers Dis. 2025 Aug 28:13872877251366669. doi: 10.1177/13872877251366669.
    PubMed         Abstract available
    
    

    
    J Am Geriatr Soc

13. MATIAS-GUIU JA, Curiel-Cid RE, Hermann BP, Loewenstein DA, et al
    A Call for Improving Clinical and Cognitive Assessments to Reduce the Gap Between Amyloid/Tau Pathology Onset and Detection of Cognitive Dysfunction.
    J Am Geriatr Soc. 2025;73:2631-2634.
    PubMed         Abstract available
    
    

    
    J Neurochem

14. LI HY, Deng YT, Guo Y, Zhang Y, et al
    Clinical Utility of Plasma GFAP and NEFL as Biomarkers for Dementia in the Community.
    J Neurochem. 2025;169:e70210.
    PubMed         Abstract available
    
    
15. HAO Q, Fu Y, Zhao YL, Zhang ZQ, et al
    Association Between Phenoage With Cognitive Function and Cerebrospinal Fluid Biomarkers of Alzheimer's Disease Pathology: The CABLE Study.
    J Neurochem. 2025;169:e70174.
    PubMed         Abstract available
    
    
16. DA CONCEICAO ARR, Marinatto J, Pinheiro LS, Rody T, et al
    The Multifaceted Role of Extracellular Vesicles in Alzheimer's Disease.
    J Neurochem. 2025;169:e70209.
    PubMed         Abstract available
    
    

    
    J Neurol

17. ZHANG Q, Lu J, Wang L, Jiao F, et al
    Evaluating (18)F-Florzolotau tau PET for Alzheimer's disease diagnosis with (18)F-Flortaucipir as reference.
    J Neurol. 2025;272:597.
    PubMed         Abstract available
    
    

    
    J Neuropsychol

18. BEZDICEK O, Motyl J, Nikolai T, Mazancova AF, et al
    Differential cued recall memory impairment in mild cognitive impairment due to Alzheimer's disease versus Parkinson's disease.
    J Neuropsychol. 2025 Aug 28. doi: 10.1111/jnp.70010.
    PubMed         Abstract available
    
    

    
    Neurobiol Dis

19. CHEN Z, Bi S, He HL, Qi Z, et al
    Multimodal imaging of glymphatic dysfunction and retinal vascular changes as biomarkers for Alzheimer's disease.
    Neurobiol Dis. 2025 Aug 25:107064. doi: 10.1016/j.nbd.2025.107064.
    PubMed         Abstract available
    
    

    
    Neurochem Res

20. WANG XC, Wu GL, Cai HY, Chu CL, et al
    Jiao-Tai-Wan Improves Cognitive Impairment by Regulating Nrf2/ARE/HO-1 Signaling Pathway in APP/PS1 Mice.
    Neurochem Res. 2025;50:268.
    PubMed         Abstract available
    
    

    
    Neurol Genet

21. OSTERMAN MD, Song YE, Lynn A, Miskimen K, et al
    Examining the Performance of Polygenic Risk Scores for Alzheimer Disease Within and Across Populations Using k-Fold Cross-Validation.
    Neurol Genet. 2024;10:e200198.
    PubMed         Abstract available
    
    

    
    Neurology

22. SCHAFFERT J, Iyengar N, Magill R, LoBue C, et al
    Clinical and Neuropsychological Profiles in People With Chronic Traumatic Encephalopathy Neuropathologic Change: Matched Case-Series Study.
    Neurology. 2025;105:e214012.
    PubMed         Abstract available
    
    

    
    PLoS One

23. FARHAN S, Haq YU, Khaliq MA, Afza S, et al
    Enhancing the early detection of Alzheimer's disease using an integrated CNN-LSTM framework: A robust approach for fMRI-based multi-stage classification.
    PLoS One. 2025;20:e0317968.
    PubMed         Abstract available
    
    
24. ZHANG Q, Deng Y, Xue M, Ni Z, et al
    Global trends in Alzheimer's disease and other dementias in adults aged 55 and above (1992-2021): An age-period-cohort analysis based on the GBD 2021.
    PLoS One. 2025;20:e0331204.
    PubMed         Abstract available
    
    

    
    Proc Natl Acad Sci U S A

25. ZHANG Y, Chen-Engerer HJ, Zhang K, Zott B, et al
    Amyloid beta-dependent neuronal silencing through synaptic decoupling.
    Proc Natl Acad Sci U S A. 2025;122:e2515113122.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Alzheimer's Disease is free of charge.